These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency. Haller RG Neurology; 2008 May; 70(20):1872-3. PubMed ID: 18474841 [No Abstract] [Full Text] [Related]
5. Adult-onset exercise intolerance due to phosphorylase b kinase deficiency. Bak H; Cordato D; Carey WF; Milder D J Clin Neurosci; 2001 May; 8(3):286-7. PubMed ID: 11386811 [TBL] [Abstract][Full Text] [Related]
6. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027 [TBL] [Abstract][Full Text] [Related]
7. Fetal-onset severe skeletal muscle glycogenosis associated with phosphorylase-b kinase deficiency. Bührer C; van Landeghem F; Brück W; Felderhoff-Müser U; Vorgerd M; Obladen M Neuropediatrics; 2000 Apr; 31(2):104-6. PubMed ID: 10832587 [TBL] [Abstract][Full Text] [Related]
8. Adult phosphorylase b kinase deficiency. Clemens PR; Yamamoto M; Engel AG Ann Neurol; 1990 Oct; 28(4):529-38. PubMed ID: 2252364 [TBL] [Abstract][Full Text] [Related]
15. Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Simmons Z; Peterlin BL; Boyer PJ; Towfighi J Muscle Nerve; 2003 Feb; 27(2):242-4. PubMed ID: 12548533 [TBL] [Abstract][Full Text] [Related]
16. A signalling role for muscle glycogen in the regulation of pace during prolonged exercise. Rauch HG; St Clair Gibson A; Lambert EV; Noakes TD Br J Sports Med; 2005 Jan; 39(1):34-8. PubMed ID: 15618337 [TBL] [Abstract][Full Text] [Related]
17. [A case of adult onset phosphoglucomutase deficiency]. Nakashima H; Suo H; Ochiai J; Sugie H; Kawamura Y Rinsho Shinkeigaku; 1992 Jan; 32(1):42-7. PubMed ID: 1385770 [TBL] [Abstract][Full Text] [Related]
18. New insights into the skeletal muscle phenotype of equine motor neuron disease: a quantitative approach. Palencia P; Quiroz-Rothe E; Rivero JL Acta Neuropathol; 2005 Mar; 109(3):272-84. PubMed ID: 15616793 [TBL] [Abstract][Full Text] [Related]
19. Effects in skeletal muscle. Young A Adv Pharmacol; 2005; 52():209-28. PubMed ID: 16492548 [TBL] [Abstract][Full Text] [Related]
20. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Baker DJ; Greenhaff PL; MacInnes A; Timmons JA Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]